-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
Amount of cash inflow (outflow) from operating activities, including discontinued operations. Operating activity cash flows include transactions, adjustments, and changes in value not defined as investing or financing activities.
-
Summary
-
Lyell Immunopharma, Inc. quarterly/annual Net Cash Provided by (Used in) Operating Activities history and growth rate from 2019 to Q1 2025.
- Lyell Immunopharma, Inc. Net Cash Provided by (Used in) Operating Activities for the quarter ending March 31, 2025 was -$54.7M, a 30.3% decline year-over-year.
- Lyell Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2024 was -$162M, a 0.79% increase from 2023.
- Lyell Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2023 was -$164M, a 3.46% increase from 2022.
- Lyell Immunopharma, Inc. annual Net Cash Provided by (Used in) Operating Activities for 2022 was -$170M, a 34.3% decline from 2021.
Net Cash Provided by (Used in) Operating Activities, Quarterly (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Quarterly Growth (%)
Net Cash Provided by (Used in) Operating Activities, Annual (USD)
Net Cash Provided by (Used in) Operating Activities, YoY Annual Growth (%)